Status:
COMPLETED
Dextenza for Post-operative Treatment of Pterygium
Lead Sponsor:
Brandon Eye Associates, PA
Conditions:
Pterygium of Both Eyes
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery
Detailed Description
In patients who undergo bilateral pterygium surgery, eyes will be randomized to receive either DEXTENZA at baseline, Month 1 and Month 2 or prednisolone x 3 months. Both eyes will receive antibiotic d...
Eligibility Criteria
Inclusion
- patients with bilateral pterygium -
Exclusion
- none
- \-
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04351737
Start Date
July 15 2020
End Date
May 23 2023
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brandon Eye Associates
Brandon, Florida, United States, 33511